We are live on ! Find out more
MDWD icon

MediWound

31 hedge funds and large institutions have $31.2M invested in MediWound in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 4

183% more call options, than puts

Call options by funds: $204K | Put options by funds: $72K

67% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 6

41% more funds holding

Funds holding: 2231 (+9)

22% more capital invested

Capital invested by funds: $25.6M → $31.2M (+$5.54M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4.29% less ownership

Funds ownership: 27.34%23.05% (-4.3%)

Holders
31
Holders Change
+9
Holders Change %
+40.91%
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
13
Increased
10
Reduced
6
Closed
4
Calls
$204K
Puts
$72K
Net Calls
+$132K
Net Calls Change
+$234K
Name Holding Trade Value Shares
Change
Change in
Stake
RA
1
Rosalind Advisors
Ontario, Canada
$6.93M -$1.65M -120,761 -20%
YLHM
2
Yelin Lapidot Holdings Management
Israel
$4.1M +$2.22M +162,341 +129%
DCM
3
DAFNA Capital Management
California
$2.69M -$944K -68,900 -27%
UIC
4
Uniplan Investment Counsel
Wisconsin
$2.08M +$11.5K +840 +0.6%
EIM
5
Essex Investment Management
Massachusetts
$1.89M +$1.28M +93,705 +242%
Wells Fargo
6
Wells Fargo
California
$1.87M -$11.5K -839 -0.6%
SIG
7
Sargent Investment Group
Maryland
$1.77M +$208K +15,214 +14%
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$1.73M -$9.59M -700,342 -85%
SBCM
9
Silverberg Bernstein Capital Management
New York
$1.21M +$84.9K +6,200 +8%
JP Morgan Chase
10
JP Morgan Chase
New York
$1.05M +$1M +73,330 +1,047,571%
Renaissance Technologies
11
Renaissance Technologies
New York
$1.04M +$230K +16,800 +30%
Balyasny Asset Management
12
Balyasny Asset Management
Illinois
$891K +$856K +62,531 New
LCM
13
Legato Capital Management
California
$681K +$655K +47,801 New
EI
14
EAM Investors
California
$624K +$600K +43,798 New
MIH
15
Meitav Investment House
Israel
$449K
Janney Montgomery Scott
16
Janney Montgomery Scott
Pennsylvania
$427K +$410K +29,948 New
Millennium Management
17
Millennium Management
New York
$407K +$391K +28,528 New
Citadel Advisors
18
Citadel Advisors
Florida
$387K +$144K +10,489 +63%
BlackRock
19
BlackRock
New York
$200K +$35K +2,559 +22%
MOS
20
MGO One Seven
Ohio
$173K
Qube Research & Technologies (QRT)
21
Qube Research & Technologies (QRT)
United Kingdom
$151K +$145K +10,613 New
Marshall Wace
22
Marshall Wace
United Kingdom
$148K +$142K +10,357 New
Osaic Holdings
23
Osaic Holdings
Arizona
$125K +$51.1K +3,729 +74%
Morgan Stanley
24
Morgan Stanley
New York
$68.7K -$10.9K -795 -14%
UBS Group
25
UBS Group
Switzerland
$51.1K +$49.2K +3,589 New

MDWD Hedge Fund Activity: Q1 2024 in Review

31 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in MediWound (MDWD) for Q1 2024, worth a combined $31.2M — up 22% from $25.6M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new MDWD positions and 4 closed out — a net gain of 9 holders — while 10 added to existing stakes and 6 trimmed.

The largest buyer was Yelin Lapidot Holdings Management, adding an estimated $2.22M. The largest seller was Point72 Asset Management, cutting an estimated $9.59M.

  • 31 institutional investors held MediWound (MDWD) as of Q1 2024, up from 22 in Q4 2023.
  • Funds reported $31.2M of MediWound stock for Q1 2024, up 22% quarter-over-quarter.
  • 13 funds opened new MediWound positions in Q1 2024 and 4 closed out, a net change of +9 holders.
  • The largest MediWound buyer in Q1 2024 was Yelin Lapidot Holdings Management, an estimated $2.22M added.
  • The largest MediWound seller in Q1 2024 was Point72 Asset Management, an estimated $9.59M sold.

Based on aggregated 13F filings for Q1 2024.